Characteristics of squamous cell lung carcinomas subdivided according to PCNA index and vessel density
. | Group A . | Group B . | Group C . | Group D . | ||||
---|---|---|---|---|---|---|---|---|
PCNA index (%) | 37.7 ± 10.4 | 42.1 ± 12.6 | 10.3 ± 6.4 | 11.0 ± 5.6 | ||||
Vessel density | 2.7 ± 1.5 | 18.3 ± 12.7 | 3.4 ± 1.9 | 15.6 ± 8.5 | ||||
Apoptosis | 0.31 ± 0.21 | 0.47 ± 0.35 | 0.28 ± 0.26 | 0.40 ± 0.34 | ||||
Pa | 0.07 | 0.14 | 0.27 | |||||
VEGF | ||||||||
Positive | 19 (95%) | 21 (95%) | 5 (18%) | 6 (33%) | ||||
Negative | 1 | 1 | 22 | 12 | ||||
P | 0.94 | <0.0001 | <0.0001 | |||||
bFGF | ||||||||
Positive | 8 (44%) | 15 (71%) | 19 (76%) | 12 (75%) | ||||
Negative | 10 | 6 | 6 | 4 | ||||
P | 0.08 | 0.03 | 0.07 | |||||
PDGF | ||||||||
Positive | 14 (70%) | 10 (55%) | 10 (45%) | 8 (47%) | ||||
Negative | 6 | 8 | 12 | 9 | ||||
P | 0.35 | 0.10 | 0.15 | |||||
Growth in mice | ||||||||
Yes | 8 (53%) | 4 (27%) | 12 (60%) | 3 (27%) | ||||
No | 7 | 11 | 8 | 8 | ||||
P | 0.13 | 0.69 | 0.18 | |||||
Metastasisb | ||||||||
Positive | 14 (74%) | 15 (68%) | 14 (52%) | 12 (66%) | ||||
Negative | 5 | 7 | 13 | 6 | ||||
P | 0.69 | 0.13 | 0.64 | |||||
Survival (weeks) | 28 | 88 | 111 | 117 | ||||
P | 0.13 | 0.03 | 0.009 |
. | Group A . | Group B . | Group C . | Group D . | ||||
---|---|---|---|---|---|---|---|---|
PCNA index (%) | 37.7 ± 10.4 | 42.1 ± 12.6 | 10.3 ± 6.4 | 11.0 ± 5.6 | ||||
Vessel density | 2.7 ± 1.5 | 18.3 ± 12.7 | 3.4 ± 1.9 | 15.6 ± 8.5 | ||||
Apoptosis | 0.31 ± 0.21 | 0.47 ± 0.35 | 0.28 ± 0.26 | 0.40 ± 0.34 | ||||
Pa | 0.07 | 0.14 | 0.27 | |||||
VEGF | ||||||||
Positive | 19 (95%) | 21 (95%) | 5 (18%) | 6 (33%) | ||||
Negative | 1 | 1 | 22 | 12 | ||||
P | 0.94 | <0.0001 | <0.0001 | |||||
bFGF | ||||||||
Positive | 8 (44%) | 15 (71%) | 19 (76%) | 12 (75%) | ||||
Negative | 10 | 6 | 6 | 4 | ||||
P | 0.08 | 0.03 | 0.07 | |||||
PDGF | ||||||||
Positive | 14 (70%) | 10 (55%) | 10 (45%) | 8 (47%) | ||||
Negative | 6 | 8 | 12 | 9 | ||||
P | 0.35 | 0.10 | 0.15 | |||||
Growth in mice | ||||||||
Yes | 8 (53%) | 4 (27%) | 12 (60%) | 3 (27%) | ||||
No | 7 | 11 | 8 | 8 | ||||
P | 0.13 | 0.69 | 0.18 | |||||
Metastasisb | ||||||||
Positive | 14 (74%) | 15 (68%) | 14 (52%) | 12 (66%) | ||||
Negative | 5 | 7 | 13 | 6 | ||||
P | 0.69 | 0.13 | 0.64 | |||||
Survival (weeks) | 28 | 88 | 111 | 117 | ||||
P | 0.13 | 0.03 | 0.009 |